Onchilles Pharma
PrivateLast Round
Series A
Extension
Nov 7, 2025
Total Funding Raised
$35.72M
Momentum Score
50 /100
Company Overview
Onchilles Pharma is a biotechnology company that develops first-in-class cytotoxic therapeutics designed to selectively kill cancer cells while preserving and activating immune function by harnessing the ELANE pathway.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Clinical Trials
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Onchilles Pharma Comps
Public and private peers based on sector, stage, and business model.
Onchilles Pharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Nov 7, 2025 | ||||
| Series A | Jun 10, 2021 | ||||
| Seed | Jul 10, 2020 | ||||
| Grant | Dec 6, 2017 |
Onchilles Pharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UCM Ventures | Series A Extension |
| Kennedy Lewis Investment Management | Series A Extension |
| LYZZ Capital | Series A Extension, Series A |
| InVivium Capital | Series A Extension |
| Lincoln Park Capital Fund | Series A Extension |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 21, 2026
Presenting a trial in progress poster at ASCO Annual Meeting.
- Mar 17, 2026
New preclinical data on NEU-002 program to be presented at AACR 2026.
Onchilles Pharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Onchilles Pharma's valuation, stock price, and market status.
